<DOC>
	<DOCNO>NCT01183715</DOCNO>
	<brief_summary>The primary purpose study evaluate safety , tolerability pharmacokinetics single oral dos PF-05161704 healthy volunteer .</brief_summary>
	<brief_title>A Single Dose Study Of PF-05161704 In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male and/or female ( non childbearing potential ) subject age 18 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week male ( 1 drink = 5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) hard liquor ) within 6 month screen . History evidence habitual use tobacco nicotine containing product within 3 month Screening positive cotinine test screen Day 0 period one</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Single Ascending Dose</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Safety Tolerability</keyword>
	<keyword>PK</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>